If you have an underactive thyroid and are considering weight-loss treatment, you have probably asked whether Mounjaro and hypothyroidism are a safe combination.
It is a sensible question, and the answer depends on your individual circumstances and medical history. For most people with a well-managed underactive thyroid, having hypothyroidism does not by itself rule out Mounjaro, but it does make an individual clinical assessment and careful thyroid monitoring especially important.
This guide explains the relationship between thyroid and Mounjaro in a clear and easy way. It covers whether you can take Mounjaro with thyroid problems, how Mounjaro and levothyroxine fit together, the important difference between an underactive thyroid and thyroid cancer, and whether Mounjaro does anything to your thyroid function itself.
Mounjaro is a brand of tirzepatide, a once-weekly injection made by Eli Lilly and used for weight management and type 2 diabetes.
Quick answer: Having an underactive thyroid (hypothyroidism), including Hashimoto's, does not automatically prevent you from taking Mounjaro. The specific thyroid contraindication for tirzepatide is a personal or family history of medullary thyroid cancer or MEN 2, which is different from an underactive thyroid. Mounjaro does not treat the thyroid and works independently of it, and you can usually continue levothyroxine, but your prescriber may wish to monitor your thyroid function because your levothyroxine requirements may change during treatment and weight loss. Treatment suitability depends on an individual clinical assessment.
Can You Take Mounjaro With Hypothyroidism?
For many people, yes. An underactive thyroid that is well controlled on levothyroxine is generally not a barrier to Mounjaro, provided a prescriber has assessed you and is satisfied that it is appropriate.
The key point is that hypothyroidism and the serious thyroid warning attached to Mounjaro are two very different things, explained in the next section.
However, Eli Lilly states that there is limited evidence specifically evaluating tirzepatide in people with hypothyroidism or Hashimoto's thyroiditis. This means treatment decisions are based on an individual's clinical assessment and the healthcare professional's judgement, rather than on studies conducted specifically in these groups.
Things to know:
- A well-managed underactive thyroid does not usually rule out Mounjaro.
- The real contraindication is thyroid cancer (MTC) or MEN 2, not hypothyroidism.
- Tirzepatide has not been specifically trialled in thyroid disease, so assessment matters.
- Your prescriber makes the final decision based on your health.
You can learn more about the medicine on our Mounjaro treatment page.
The Thyroid Warning Explained: Cancer Is Not the Same as an Underactive Thyroid
This is the single most important thing to understand, because it causes a lot of unnecessary worry.
Tirzepatide carries a warning related to the thyroid, but it is about a specific and rare type of thyroid cancer, not the common underactive thyroid that millions of people live with.
Eli Lilly states that tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), or with the genetic condition multiple endocrine neoplasia syndrome type 2 (MEN 2). This warning is based on findings from rodent studies and is reflected in the product's prescribing information as a precaution.
An underactive thyroid, whether caused by Hashimoto's thyroiditis or another reason, is a completely different condition. It means your thyroid produces too little hormone, and it is treated with replacement hormone. It is not thyroid cancer, and it is not what the contraindication refers to.
| Thyroid situation | Relationship to Mounjaro |
|---|---|
| Underactive thyroid (hypothyroidism) | Not generally considered a contraindication; suitability should be assessed individually. |
| Hashimoto's thyroiditis | An autoimmune cause of hypothyroidism; treated the same way, not a contraindication in itself. |
| Medullary thyroid carcinoma (MTC) | A contraindication; Mounjaro should not be used. |
| MEN 2 (genetic syndrome) | A contraindication; Mounjaro should not be used. |
If you are unsure which applies to you, tell your prescriber your exact diagnosis, because the difference changes everything.
Mounjaro and Levothyroxine: Taking Them Together
Most people with an underactive thyroid take levothyroxine, the standard NHS replacement for thyroid hormone, and want to know how it fits with Mounjaro.
In general, levothyroxine and Mounjaro can be used together, and there is no known direct interaction between them. However, your prescriber may want to monitor your thyroid for two practical reasons.
Why Thyroid Monitoring Matters
Levothyroxine dosing is finely balanced and is checked with regular blood tests that measure your TSH level. Two things about Mounjaro can shift that balance.
First, as you lose weight, your body's requirement for thyroid hormone can change, because levothyroxine needs are partly related to body weight.
Second, Mounjaro slows the rate at which the stomach empties, which can alter how a medicine like levothyroxine is absorbed. Individual cases have reported changes in thyroid-function measurements or levothyroxine requirements after starting tirzepatide.
The practical implication is that your prescriber or GP may wish to monitor your thyroid function while you are taking Mounjaro and adjust your levothyroxine if needed. Never change your levothyroxine dose yourself.
Timing and Absorption
Levothyroxine is usually taken on an empty stomach, well apart from food and other medicines, to help it absorb properly.
Because Mounjaro affects digestion, it is worth keeping your levothyroxine routine consistent and asking your pharmacist for advice on timing. Keeping that routine steady makes your thyroid blood tests easier to interpret.
Does Mounjaro Help Thyroid Function?
This is a common question. Mounjaro is not licensed to treat hypothyroidism or improve thyroid function.
Mounjaro acts on hormone pathways involved in appetite regulation and blood-glucose control, the GIP and GLP-1 receptors, and it operates independently of your thyroid. It does not replace thyroid hormone, it does not fix an underactive thyroid, and it is not a substitute for levothyroxine.
Mounjaro for Hypothyroid Patients Struggling With Weight
Many people with an underactive thyroid find weight harder to lose, particularly if their thyroid levels have not yet been optimised, because untreated or inadequately treated hypothyroidism can contribute to symptoms such as fatigue and weight gain.
The usual first step is to get the thyroid itself well treated. Once thyroid function is appropriately managed and weight remains a concern, Mounjaro may be considered clinically appropriate as part of a wider management plan, always alongside a reduced-calorie diet and increased activity, and always after a clinical assessment.
For a broader look at the options, our medical weight loss hub explains how medically supervised treatments fit alongside lifestyle change.
Here is a simple comparison of the choices hypothyroid patients often weigh up.
| Option | What it does | Best thought of as |
|---|---|---|
| Optimising thyroid treatment (levothyroxine) | Corrects the underlying hormone deficiency. | The essential foundation for anyone with hypothyroidism. |
| Diet and lifestyle change | Supports weight and general health. | Necessary alongside any treatment. |
| Mounjaro (tirzepatide) | Reduces appetite to support weight loss. | An add-on option once the thyroid is well managed, if clinically suitable. |
This does not mean one option is better than another; they address different things, and a prescriber will help you decide what is appropriate.
Mounjaro and Hashimoto's Thyroiditis
Hashimoto's thyroiditis is the most common cause of an underactive thyroid in the UK. It is an autoimmune condition in which the immune system gradually reduces the thyroid's ability to make hormones.
From a Mounjaro perspective, Hashimoto's-related hypothyroidism is generally managed in the same way as other causes of hypothyroidism, usually with levothyroxine, and it is not in itself a reason you cannot have Mounjaro. The same principles apply: it is not the thyroid cancer that the contraindication refers to, monitoring is important, and an individual assessment is essential.
What the Evidence Says
Mounjaro's weight-loss effect is well evidenced in the general population, even though it has not been studied specifically in thyroid disease.
In the pivotal SURMOUNT-1 trial, published in the New England Journal of Medicine, 2,539 adults with obesity, or overweight with a weight-related complication, took tirzepatide or placebo for 72 weeks. Average weight reductions reached up to 22.5% on the highest dose, compared with 2.4% on placebo.
People with treated hypothyroidism may have been represented within the broader study population, although dedicated analyses in this group are limited, the general principles of benefit and risk still apply, but the lack of thyroid-specific trials is exactly why personal assessment and monitoring matter. Results vary between individuals.
Getting Assessed Safely
If you have any thyroid condition and are considering Mounjaro, a proper clinical assessment is not a formality; it is an important safeguard that helps ensure treatment is appropriate.
- Declare your thyroid diagnosis precisely. Say whether you have hypothyroidism, Hashimoto's, or any history of thyroid cancer or MEN 2. The difference is decisive.
- List your medicines. Include levothyroxine and any other thyroid or regular medicines.
- Expect monitoring. A responsible service will support thyroid function checks and adjust levothyroxine through your GP or prescriber as needed.
- Use a regulated pharmacy. A GPhC-registered pharmacy with independent prescriber review helps ensure medication is supplied through an appropriately regulated service with clinical oversight.
You can begin an assessment for Mounjaro treatment online through a regulated route. This medicine should only be used under the supervision of an appropriately qualified prescriber. Treatment suitability depends on an individual clinical assessment, and your prescriber will determine the appropriate treatment for you.
Key Takeaways
- An underactive thyroid (hypothyroidism), including Hashimoto's, does not by itself rule out Mounjaro.
- The tirzepatide thyroid contraindication is medullary thyroid cancer or MEN 2, which is not the same as an underactive thyroid.
- Mounjaro does not treat or improve thyroid function; it works independently on appetite hormones.
- Levothyroxine and Mounjaro can usually be taken together, but thyroid monitoring is important because your levothyroxine needs can change.
- Tirzepatide has not been specifically studied in thyroid disease, so individual assessment matters.
- Ensuring your thyroid condition is appropriately managed is an important part of assessing whether Mounjaro may be suitable for you.
- Mounjaro is made by Eli Lilly and should only be used under prescriber supervision.
Medical Disclaimer
This article is for general information and educational purposes only. It explains the relationship between Mounjaro (tirzepatide) and hypothyroidism, including whether you can take Mounjaro with an underactive thyroid or levothyroxine and how the thyroid cancer warning differs from an underactive thyroid, but it does not constitute medical advice and is not a substitute for consultation with a qualified healthcare professional, pharmacist or prescriber.
Nothing here recommends Mounjaro or any dose, and it does not provide dosing instructions for Mounjaro or for levothyroxine, nor does it guarantee any weight-loss outcome. Tirzepatide has not been studied specifically in people with thyroid disease, so decisions rely on individual clinical judgement. If you have any thyroid condition, including hypothyroidism, Hashimoto's thyroiditis, or any personal or family history of medullary thyroid carcinoma or MEN 2, you must tell your prescriber, because these situations are treated very differently.
Do not start, stop or change Mounjaro or your levothyroxine without professional advice, and continue any thyroid blood-test monitoring your GP or prescriber arranges. Treatment suitability depends on an individual clinical assessment. This medicine should only be used under the supervision of an appropriately qualified prescriber, and results vary between individuals.